Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.
Stanford is now accepting new patients for this trial.
- other : Blood draw
Ages Eligible For Study:
- Patients must have a known or suspected cervical cancer. - Age >=18 years. - Patients must have no other active cancer at the time of diagnosis. - Patients must have no history of a hysterectomy. - Patients must be able to give informed consent. - Patients must be willing to undergo a biopsy of the cervical tumor to provide tissue for the study. - Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of therapy, for assessment of lymph nodes.